A stable GH31 α-glucosidase as a model system for the study of mutations leading to human glycogen storage disease type II
GH31 glycosidases are widespread across organisms, but remarkably, less than 1% of them have been biochemically characterised to date. Among them, human lysosomal acid α-glucosidase (GAA) stands out due to its link to Pompe disease, a rare lysosomal storage disorder caused by its deficiency. This di...
Saved in:
| Main Authors: | Roberta Iacono, Francesca Maria Pia Paragliola, Andrea Strazzulli, Marco Moracci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2025.2468859 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cold-Active Lipase from the Ice Cave <i>Psychrobacter</i> SC65A.3 Strain, a Promising Biocatalyst for Silybin Acylation
by: Victoria I. Paun, et al.
Published: (2024-10-01) -
sp2-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease
by: Manuel González-Cuesta, et al.
Published: (2022-12-01) -
The Extremophiles: Adaptation Mechanisms and Biotechnological Applications
by: Gorji Marzban, et al.
Published: (2025-04-01) -
Results of orthodontic procedure in a patient with classic infantile Pompe disease
by: Carla Maria Grimaldi, et al.
Published: (2025-07-01) -
Lack of vigilance is the main factor of late diagnosis of glycogen storage disease type II in the Republic of Kazakhstan
by: L. A. Kuzina, et al.
Published: (2018-04-01)